Inhibrx INBX
$ 14.09
0.79%
Annual report 2023
added 02-28-2024
Inhibrx Balance Sheet 2011-2024 | INBX
Annual Balance Sheet Inhibrx
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-275 M | -269 M | -125 M | -95.9 M | 30.2 M | 7.39 M | 1.19 M | - | - | - | - | - | - |
Long Term Debt |
1.11 M | 3.17 M | 5.03 M | 29.2 M | 30.4 M | 3.56 M | 9.49 M | - | - | - | - | - | - |
Long Term Debt Current |
2.06 M | 1.86 M | 1.67 M | 1.5 M | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | 36.9 M | 99.5 M | 51.4 M | 30.7 M | - | - | - | - | - | - |
Total Current Liabilities |
56.3 M | 27.6 M | 22.5 M | 31.4 M | - | - | - | - | - | - | - | - | - |
Total Liabilities |
264 M | 233 M | 98.1 M | 68.3 M | 120 M | 67.6 M | 39.7 M | - | - | - | - | - | - |
Deferred Revenue |
- | 166 K | 2.03 M | 3.08 M | 7.94 M | - | - | - | - | - | - | - | - |
Retained Earnings |
-614 M | -372 M | -227 M | -145 M | -69.3 M | -17.9 M | -28.8 M | - | - | - | - | - | - |
Total Assets |
308 M | 291 M | 150 M | 144 M | 26.5 M | 9.98 M | 17.2 M | - | - | - | - | - | - |
Cash and Cash Equivalents |
278 M | 274 M | 131 M | 129 M | 11.5 M | - | - | - | - | - | - | - | - |
Book Value |
43.5 M | 58.1 M | 52.4 M | 75.5 M | -93.6 M | -57.6 M | -22.4 M | - | - | - | - | - | - |
Total Shareholders Equity |
43.5 M | 58.1 M | 52.4 M | 75.5 M | -93.6 M | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Balance Sheet Inhibrx
2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
1.65 M | 2.17 M | 2.68 M | 3.17 M | 3.66 M | 4.13 M | 4.59 M | 5.03 M | 5.47 M | 5.9 M | 6.31 M | 6.71 M | 6.71 M | 6.71 M | 6.71 M | 6.7 M | 6.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
243 M | 238 M | 239 M | 233 M | 200 M | 198 M | 134 M | 98.1 M | 101 M | 97.6 M | 63.9 M | 68.3 M | 68.3 M | 68.3 M | 68.3 M | 60.6 M | 60.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | 119 K | 149 K | 166 K | 440 K | 717 K | 1.23 M | 2.03 M | 2.77 M | 3.24 M | 4.08 M | 3.08 M | 3.08 M | 3.08 M | 3.08 M | 7.94 M | 7.94 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-520 M | -468 M | -421 M | -372 M | -331 M | -296 M | -258 M | -227 M | -206 M | -185 M | -165 M | -145 M | -145 M | -145 M | -145 M | -69.3 M | -69.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
373 M | 213 M | 254 M | 291 M | 165 M | 193 M | 161 M | 150 M | 129 M | 142 M | 125 M | 144 M | 144 M | 144 M | 144 M | 26.5 M | 26.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
337 M | 192 M | 234 M | 274 M | 146 M | 176 M | 143 M | 131 M | 113 M | 126 M | 108 M | 129 M | 129 M | 129 M | 129 M | 11.5 M | 11.5 M | - | - | 2.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
130 M | -24.8 M | 15.1 M | 58.1 M | -35 M | -4.92 M | 27.4 M | 52.4 M | 28.2 M | 44.3 M | 60.6 M | 75.5 M | 75.5 M | 75.5 M | 75.5 M | -34.1 M | -34.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
130 M | -24.8 M | 15.1 M | 58.1 M | -35 M | -4.92 M | 27.4 M | 52.4 M | 28.2 M | 44.3 M | 60.6 M | 75.5 M | 75.5 M | 75.5 M | 75.5 M | -93.6 M | -93.6 M | -59.2 M | -60.6 M | -57.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency